These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30240679)

  • 41. Benefits of Fixed Dose Combination of Ramipril/Amlodipine in Hypertensive Diabetic Patients: A Subgroup Analysis of RAMONA Trial.
    Simonyi G
    Chin Med J (Engl); 2016 May; 129(10):1224-8. PubMed ID: 27174332
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study.
    Hong BK; Park CG; Kim KS; Yoon MH; Yoon HJ; Yoon JH; Yang JY; Choi YJ; Cho SY
    Am J Cardiovasc Drugs; 2012 Jun; 12(3):189-95. PubMed ID: 22462558
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pharmacological and clinical properties of AIMIX® combination tablets LD&HD, fixed-dose combination of irbesartan and amlodipine besilate].
    Mori M; Takahashi S
    Nihon Yakurigaku Zasshi; 2013 Jul; 142(1):39-46. PubMed ID: 23842227
    [No Abstract]   [Full Text] [Related]  

  • 44. A randomized, comparative, multicentric evaluation of atenolol/amlodipine combination with atenolol alone in essential hypertensive patients.
    Pareek A; Salkar H; Mulay P; Desai S; Chandurkar N; Redkar N
    Am J Ther; 2010; 17(1):46-52. PubMed ID: 19535971
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Triple-drug, fixed-dose combinations for the treatment of hypertension: focus on olmesartan/amlodipine/hydrochlorothiazide combination.
    Chrysant SG
    Drugs Today (Barc); 2011 Mar; 47(3):197-206. PubMed ID: 21494697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cost-effectiveness analysis of celecoxib versus non-selective non-steroidal anti-inflammatory drug therapy for the treatment of osteoarthritis in Spain: A current perspective].
    De Lossada A; Oteo-Álvaro Á; Giménez S; Oyagüez I; Rejas J
    Semergen; 2016; 42(4):235-43. PubMed ID: 26006311
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence.
    Simonyi G; Ferenci T; Alföldi S; Farsang C
    J Int Med Res; 2016 Oct; 44(5):1087-1091. PubMed ID: 27435392
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
    Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M
    J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
    Liew D; Park HJ; Ko SK
    Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Celecoxib for osteoarthritis.
    Rowan-Robinson K
    Br J Community Nurs; 2019 Oct; 24(10):501-502. PubMed ID: 31604050
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparison of Fixed-dose Combinations of Amlodipine/Losartan Potassium/Chlorthalidone and Amlodipine/Losartan Potassium in Patients With Stage 2 Hypertension Inadequately Controlled With Amlodipine/Losartan Potassium: A Randomized, Double-blind, Multicenter, Phase III Study.
    Hong SJ; Jeong HS; Han SH; Chang KY; Hong BK; Lee BK; Chae SC; Kim WS; Park CG; Heo JH; Lee SU; Kim YD; Kim KS; Choi JH; Kang HJ; Kim JJ; Kang SM; Choi YJ; Shin JH; Chun KJ; Shin DG; Park SH; Kwan J; Choi YJ; Jeong MH; Chae JK; Kim DW; Cho JR; Han KR; Won KH; Park SH; Lee SK; Kim SH; Jung J; Kim CH
    Clin Ther; 2017 Oct; 39(10):2049-2060. PubMed ID: 28939406
    [TBL] [Abstract][Full Text] [Related]  

  • 52. I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
    Bobrie G;
    Clin Ther; 2012 Aug; 34(8):1705-19. PubMed ID: 22853848
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subgroup analyses of an efficacy and safety study of concomitant administration of amlodipine besylate and olmesartan medoxomil: evaluation by baseline hypertension stage and prior antihypertensive medication use.
    Oparil S; Lee J; Karki S; Melino M
    J Cardiovasc Pharmacol; 2009 Nov; 54(5):427-36. PubMed ID: 19730391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
    Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG;
    Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Short-Term Cardioprotective Effects of the Original Perindopril/Amlodipine Fixed-Dose Combination in Patients with Stable Coronary Artery Disease: Results of the PAPA-CAD Study.
    Forster T; Dézsi CA
    Adv Ther; 2016 Oct; 33(10):1771-1781. PubMed ID: 27475811
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combination of telmisartan plus amlodipine in the treatment of hypertension: review of results.
    Oigman W; Neves MF; Gismondi RA
    Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1509-17. PubMed ID: 21090924
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
    Ferri C; Croce G; Desideri G
    Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and tolerability of olmesartan/amlodipine combination therapy in patients with mild-to-severe hypertension: focus on 24-h blood pressure control.
    Parati G; Ochoa JE; Ramos C; Hoshide S; Lonati L; Bilo G
    Ther Adv Cardiovasc Dis; 2010 Oct; 4(5):301-13. PubMed ID: 20921092
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Echocardiographic changes and treatment goal rates after a 6-month combined treatment with amlodipine and losartan: a validation study in Andean countries (METAL study).
    Pérez Carreño JG; Romero JD; Villar Centeno JC;
    Ther Adv Cardiovasc Dis; 2013 Oct; 7(5):237-45. PubMed ID: 24096616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of valsartan/hydrochlorothiazide fixed-dose combination compared with amlodipine monotherapy as first-line therapy for mild to moderate hypertension.
    Chao CL; Lin YH; Lin LC; Lin LY; Tsai CT; Wang YC; Hwang JJ; Chen JC; Chiang FT
    J Int Med Res; 2009; 37(2):289-97. PubMed ID: 19383221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.